Olema Pharmaceuticals Inc (OLMA) Insider Trading
- $53,844,919.13
- $48,913,124.99
- Dec. 17, 2024
- Cyrus Harmon
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 17, 2024 | Director | 700,761 | $6.75 | Sell | $4,730,136.75 | |
Dec. 10, 2024 | Director | 8,256 | $9.37 | Sell | $77,358.72 | |
Dec. 10, 2024 | Insider | 12,452 | $9.38 | Sell | $116,799.76 | |
Dec. 10, 2024 | CEO | 52,328 | $9.37 | Sell | $490,313.36 | |
Aug. 1, 2024 | Major Shareholder | 2,400,000 | $14.91 | Sell | $35,784,000.00 | |
July 29, 2024 | Director | 4,066 | $15.58 | Sell | $63,348.28 | |
July 11, 2024 | Director | 5,000 | $12.26 | Sell | $61,300.00 | |
June 28, 2024 | Director | 20,000 | $10.77 | Sell | $215,400.00 | |
June 3, 2024 | Director | 5,000 | $10.93 | Sell | $54,650.00 | |
May 31, 2024 | Director | 15,000 | $9.41 | Sell | $141,150.00 | |
May 6, 2024 | Director | 5,000 | $10.92 | Sell | $54,600.00 | |
April 30, 2024 | Director | 15,000 | $9.51 | Sell | $142,650.00 | |
March 28, 2024 | Director | 20,000 | $10.97 | Sell | $219,400.00 | |
Feb. 29, 2024 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
Jan. 31, 2024 | Director | 25,000 | $12.23 | Sell | $305,750.00 | |
Dec. 6, 2023 | Major Shareholder | 100,000 | $11.60 | Buy | $1,160,000.00 | |
Nov. 30, 2023 | Director | 25,000 | $12.57 | Sell | $314,250.00 | |
Nov. 21, 2023 | CEO | 29,293 | $14.88 | Sell | $435,879.84 | |
Nov. 21, 2023 | Director | 4,192 | $14.86 | Sell | $62,293.12 | |
Nov. 21, 2023 | Insider | 7,461 | $14.84 | Sell | $110,721.24 | |
Nov. 8, 2023 | Insider | 200 | $17.61 | Sell | $3,522.00 | |
Nov. 3, 2023 | Insider | 541 | $17.51 | Sell | $9,472.91 | |
Nov. 2, 2023 | Director | 5,000 | $15.64 | Sell | $78,200.00 | |
Nov. 1, 2023 | Insider | 6,668 | $15.02 | Sell | $100,153.36 | |
Oct. 31, 2023 | Director | 25,000 | $12.05 | Sell | $301,250.00 | |
Sept. 29, 2023 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
Sept. 19, 2023 | Insider | 20,000 | $12.67 | Sell | $253,400.00 | |
Sept. 12, 2023 | Director | 1,505,932 | $9.84 | Buy | $14,818,370.88 | |
Sept. 5, 2023 | Director | 10,000 | $11.62 | Sell | $116,200.00 | |
Aug. 31, 2023 | Director | 15,000 | $9.36 | Sell | $140,400.00 | |
June 8, 2023 | Director | 10,000 | $6.30 | Sell | $63,000.00 | |
June 5, 2023 | Director | 5,000 | $6.04 | Sell | $30,200.00 | |
June 10, 2022 | Director | 200,000 | $4.03 | Buy | $806,000.00 | |
March 10, 2022 | Insider | 5,253 | $4.75 | Sell | $24,951.75 | |
Jan. 10, 2022 | Insider | 5,251 | $6.85 | Sell | $35,969.35 | |
Dec. 10, 2021 | Insider | 5,251 | $10.39 | Sell | $54,557.89 | |
Nov. 30, 2021 | Director | 739,675 | $9.39 | Buy | $6,945,548.25 | |
Nov. 29, 2021 | CTO | 400 | $24.76 | Sell | $9,904.00 | |
Oct. 19, 2021 | CTO | 12,000 | $27.98 | Sell | $335,760.00 | |
Oct. 14, 2021 | CEO | 5,000 | $30.47 | Sell | $152,350.00 | |
Oct. 11, 2021 | Insider | 5,251 | $27.90 | Sell | $146,502.90 | |
Sept. 27, 2021 | CEO | 1,085 | $30.07 | Sell | $32,625.95 | |
Sept. 20, 2021 | CTO | 12,000 | $26.30 | Sell | $315,600.00 | |
Sept. 10, 2021 | Insider | 5,251 | $29.38 | Sell | $154,274.38 | |
Sept. 1, 2021 | CEO | 871 | $30.05 | Sell | $26,173.55 | |
Aug. 19, 2021 | CTO | 12,000 | $24.97 | Sell | $299,640.00 | |
Aug. 10, 2021 | Insider | 5,251 | $25.71 | Sell | $135,003.21 | |
July 20, 2021 | CTO | 4,123 | $25.63 | Sell | $105,672.49 | |
July 12, 2021 | Insider | 5,251 | $26.51 | Sell | $139,204.01 | |
June 18, 2021 | CTO | 12,000 | $24.80 | Sell | $297,600.00 |
Insiders are both buying and selling Olema Pharmaceuticals Inc stock.
The insider traders at Olema Pharmaceuticals Inc are: Cyrus Harmon, Kinney Horn, Sean Bohen, David C Myles, Bvf Partners L P/Il, Biocapital Advisors L Paradigm, G. Walmsley Graham, Naseem Zojwalla, and Cormorant Asset Management, Lp
The most active insider trader at Olema Pharmaceuticals Inc is Cyrus Harmon with 26 trades.
Biocapital Advisors L Paradigm has sold the most Olema Pharmaceuticals Inc stock with a total value of $71,568,000.00.
G. Walmsley Graham has bought the most Olema Pharmaceuticals Inc stock with a total value of $44,080,000.00.
The most recent insider trade for Olema Pharmaceuticals Inc was on Dec. 17, 2024.
The single biggest insider buy for Olema Pharmaceuticals Inc was from G. Walmsley Graham with a total value of $22,040,000.00 on Nov. 23, 2020.
The single biggest insider sell for Olema Pharmaceuticals Inc was from Biocapital Advisors L Paradigm with a total value of $35,784,000.00 on Aug. 1, 2024.